|
WSB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.844300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.585800E-02 |
| Normal-vs-Stage2 |
2.180200E-01 |
| Normal-vs-Stage3 |
1.290010E-01 |
| Normal-vs-Stage4 |
3.424000E-01 |
| Stage1-vs-Stage2 |
5.327200E-01 |
| Stage1-vs-Stage3 |
9.939400E-01 |
| Stage1-vs-Stage4 |
7.494600E-01 |
| Stage2-vs-Stage3 |
6.741200E-01 |
| Stage2-vs-Stage4 |
6.465600E-01 |
| Stage3-vs-Stage4 |
7.822800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.328300E-02 |
| Normal-vs-AfricanAmerican |
7.955200E-04 |
| Normal-vs-Asian |
6.424600E-01 |
| Caucasian-vs-AfricanAmerican |
2.734000E-02 |
| Caucasian-vs-Asian |
3.001000E-01 |
| AfricanAmerican-vs-Asian |
9.461800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.042310E-02 |
| Normal-vs-Female |
1.071550E-02 |
| Male-vs-Female |
6.418200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.700240E-01 |
| Normal-vs-Extreme_Weight |
3.019200E-01 |
| Normal-vs-Obese |
5.076900E-03 |
| Normal-vs-Extreme_Obese |
4.512000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.285800E-01 |
| Normal_Weight-vs-Obese |
1.913580E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.172200E-01 |
| Extreme_Weight-vs-Obese |
4.332000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.103000E-01 |
| Obese-vs-Extreme_Obese |
5.280800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.221770E-01 |
| Normal-vs-Age(41-60Yrs) |
1.062860E-03 |
| Normal-vs-Age(61-80Yrs) |
8.360200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.898000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.348600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.519200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.827600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.337600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.126200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.037500E-03 |
| Normal-VS-Type2 PRCC |
1.144630E-01 |
| Normal-VS-KIRP CIMP |
4.696600E-01 |
| Normal-VS-Unclassified PRCC |
3.560300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.052200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.194400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.606200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.877350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.870200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.403500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.034600E-01 |
| Normal-vs-N1 |
1.226420E-01 |
| Normal-vs-N2 |
4.418600E-01 |
| N0-vs-N1 |
1.904440E-01 |
| N0-vs-N2 |
7.236000E-01 |
| N1-vs-N2 |
7.861000E-01 |
|
|
